Cite
MLA Citation
William Jeffery Edenfield et al.. “A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers.” Oncologist, vol. 26, 2021, pp. e1499–e1507. http://access.bl.uk/ark:/81055/vdc_100139933539.0x000036